We refer to the earlier announcements in relation to the DRP. Unless otherwise stated, all terms used herein shall have the same meaning as defined in the said announcements.

On behalf of the Board, AmInvestment Bank wishes to announce that: 

(i) the option for shareholders of Duopharma Biotech to elect to reinvest in whole or in part their cash dividend into new Duopharma Biotech Shares, in lieu of receiving cash, shall apply to the entire portion of the second interim dividend of 1.8 sen per Duopharma Biotech Share in respect of the financial year ended 31 December 2022 (“Second Interim Dividend 2022” or “Dividend”);

(ii) the entitlement date for the Second Interim Dividend 2022 and DRP has been fixed on 10 April 2023 (“Entitlement Date”); and

(iii) the issue price of the new Duopharma Biotech Shares to be issued pursuant to the DRP has been fixed today (“Price-Fixing Date”) at RM1.35 per new Duopharma Biotech Share (“Issue Price”). 

For information purposes, the Issue Price is computed based on the five (5)-day volume weighted average market price (“VWAMP”) of RM1.5158 per Duopharma Biotech Share up to and including 24 March 2023, being the last trading day prior to the Price-Fixing Date after adjusting for the following:

(a) the Second Interim Dividend 2022; and 

(b) a discount of RM0.1478 or approximately 9.87% to the five (5)-day ex-Dividend VWAMP of RM1.4978 per Duopharma Biotech Share.

The Notice of Election (including the Dividend Reinvestment Form) will be sent by electronic mail to shareholders of Duopharma Biotech who have registered their email addresses with Bursa Malaysia Depository Sdn Bhd (“Bursa Depository”) on 12 April 2023, after the Entitlement Date. For shareholders of Duopharma Biotech who have yet to register their email addresses with Bursa Depository, the hardcopy of the Notice of Election (including the Dividend Reinvestment Form) will be sent by ordinary post. A copy of the DRP Statement will be available at the Company’s website for shareholders to view and download on 12 April 2023. The election period for the DRP will close on 26 April 2023.

Barring any unforeseen circumstances, the new Duopharma Biotech Shares arising from the DRP will be listed on the Main Market of Bursa Securities on 10 May 2023.

This Announcement is dated 27 March 2023.